Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 567

1.

Effect of LSR polymorphism on blood lipid levels and age-specific epistatic interaction with the APOE common polymorphism.

Xie T, Stathopoulou MG, Akbar S, Oster T, Siest G, Yen FT, Visvikis-Siest S.

Clin Genet. 2018 Apr;93(4):846-852. doi: 10.1111/cge.13181.

PMID:
29178324
2.

Next generation sequencing and immuno-histochemistry profiling identify numerous biomarkers for personalized therapy of endometrioid endometrial carcinoma.

El Shamieh S, Saleh F, Fawaz MA, Siest G, Farhat FS, Visvikis-Siest S.

Clin Chem Lab Med. 2017 Nov 27;56(1):e19-e22. doi: 10.1515/cclm-2017-0208. No abstract available.

PMID:
28763293
3.

VEGF-related polymorphisms identified by GWAS and risk for major depression.

Xie T, Stathopoulou MG, de Andrés F, Siest G, Murray H, Martin M, Cobaleda J, Delgado A, Lamont J, Peñas-LIedó E, LLerena A, Visvikis-Siest S.

Transl Psychiatry. 2017 Mar 7;7(3):e1055. doi: 10.1038/tp.2017.36.

4.

Progress in pharmacogenetics: consortiums and new strategies.

Maroñas O, Latorre A, Dopazo J, Pirmohamed M, Rodríguez-Antona C, Siest G, Carracedo Á, LLerena A.

Drug Metab Pers Ther. 2016 Mar;31(1):17-23. doi: 10.1515/dmpt-2015-0039. Review.

5.

Systems medicine, personalized health and therapy.

Siest G, Auffray C, Taniguchi N, Ingelman-Sundberg M, Murray H, Visvikis-Siest S, Ansari M, Marc J, Jacobs P, Meyer U, Van Schaik RH, Müller MM, Wevers RA, Simmaco M, Kussmann M, Manolopoulos VG, Alizadeh BZ, Beastall G, Németh G.

Pharmacogenomics. 2015;16(14):1527-39. doi: 10.2217/pgs.15.103. Epub 2015 Sep 24.

PMID:
26401575
6.

Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe.

Malentacchi F, Mancini I, Brandslund I, Vermeersch P, Schwab M, Marc J, van Schaik RH, Siest G, Theodorsson E, Pazzagli M, Di Resta C; European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) – European Society of Pharmacogenomics and Personalised Therapy (ESPT) Joint Working Group on Personalized Laboratory Medicine (WG-PLM).

Drug Metab Pers Ther. 2015 Jun;30(2):121-8. doi: 10.1515/dmdi-2015-0012.

7.

Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe.

Malentacchi F, Mancini I, Brandslund I, Vermeersch P, Schwab M, Marc J, van Schaik RH, Siest G, Theodorsson E, Pazzagli M, Di Resta C; European Federation of Clinical Chemistry and Laboratory Medicine (EFLM); European Society of Pharmacogenomics and Personalised Therapy (ESPT) Joint Working Group on Personalized Laboratory Medicine (WG-PLM).

Clin Chem Lab Med. 2015 Jun;53(7):981-8.

8.

Genetic determined low response to thienopyridines is associated with higher systemic inflammation in smokers.

Shahabi P, Cuisset T, Stathopoulou MG, Morange PE, Grosdidier C, Herbeth B, Siest G, Alessi MC, Visvikis-Siest S.

Pharmacogenomics. 2015;16(5):459-69. doi: 10.2217/pgs.15.17.

PMID:
25916518
9.

CYP 2C19 and UDP-glucuronosyltransferases not only for drugs but also for endobiotics.

Siest G, Fournel-Gigleux S, Magdalou J.

Drug Metabol Drug Interact. 2014;29(4):207-9. doi: 10.1515/dmdi-2014-0030. No abstract available.

PMID:
25367614
10.

Conference scene: pharmacogenomics: from cell to clinic (part 2).

Siest G, Medeiros R, Melichar B, Stathopoulou M, Van Schaik RH, Cacabelos R, Abt PM, Monteiro C, Gurwitz D, Queiroz J, Mota-Filipe H, Ndiaye NC, Visvikis-Siest S.

Pharmacogenomics. 2014 Apr;15(6):739-44. doi: 10.2217/pgs.14.36.

11.

Human cytochrome P450 epoxygenases: variability in expression and role in inflammation-related disorders.

Shahabi P, Siest G, Meyer UA, Visvikis-Siest S.

Pharmacol Ther. 2014 Nov;144(2):134-61. doi: 10.1016/j.pharmthera.2014.05.011. Epub 2014 Jun 2. Review.

PMID:
24882266
12.

Pharmacogenomics: from cell to clinic (Part 1).

Siest G, Medeiros R, Melichar B, Stathopoulou M, Van Schaik RH, Cacabelos R, Abt PM, Monteiro C, Gurwitz D, Queiroz J, Mota-Filipe H, Ndiaye NC, Visvikis-Siest S.

Pharmacogenomics. 2014 Apr;15(5):593-9. doi: 10.2217/pgs.14.35.

13.

Systems medicine, stratified medicine, personalized medicine but not precision medicine.

Siest G.

Drug Metabol Drug Interact. 2014;29(1):1-2. doi: 10.1515/dmdi-2013-0068. No abstract available.

PMID:
24468611
14.

Conference Scene: Systems biology and personalized health science and translation.

Siest G, Ndiaye NC, El Shamieh S, Shahabi P, Stathopoulou M, Saleh AS, Godjo T, Albertini L, Visvikis-Siest S.

Pharmacogenomics. 2013 Dec;14(16):1953-64. doi: 10.2217/pgs.13.201.

15.

Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.

Shahabi P, Siest G, Visvikis-siest S.

Drug Metab Rev. 2014 Feb;46(1):33-56. doi: 10.3109/03602532.2013.837916. Epub 2013 Sep 16. Review.

PMID:
24040964
16.

Influence of genetic variations on levels of inflammatory markers of healthy subjects at baseline and one week after clopidogrel therapy; results of a preliminary study.

Shahabi P, Siest G, Herbeth B, Lambert D, Masson C, Hulot JS, Bertil S, Gaussem P, Visvikis-Siest S.

Int J Mol Sci. 2013 Aug 8;14(8):16402-13. doi: 10.3390/ijms140816402.

17.

Pharmacogenomics: from cell to clinic.

Siest G.

Drug Metabol Drug Interact. 2013;28(3):133. doi: 10.1515/dmdi-2013-0035. No abstract available.

PMID:
23902693
18.

Newly identified synergy between clopidogrel and calcium-channel blockers for blood pressure regulation possibly involves CYP2C19 rs4244285.

Stathopoulou MG, Monteiro P, Shahabi P, Peñas-Lledó E, El Shamieh S, Silva Santos L, Thilly N, Siest G, Llerena A, Visvikis-Siest S.

Int J Cardiol. 2013 Oct 3;168(3):3057-8. doi: 10.1016/j.ijcard.2013.04.097. Epub 2013 May 3. No abstract available.

PMID:
23643422
19.
20.

Epistatic study reveals two genetic interactions in blood pressure regulation.

Ndiaye NC, Said el S, Stathopoulou MG, Siest G, Tsai MY, Visvikis-Siest S.

BMC Med Genet. 2013 Jan 8;14:2. doi: 10.1186/1471-2350-14-2.

21.

Dairy product consumption, calcium intakes, and metabolic syndrome-related factors over 5 years in the STANISLAS study.

Samara A, Herbeth B, Ndiaye NC, Fumeron F, Billod S, Siest G, Visvikis-Siest S.

Nutrition. 2013 Mar;29(3):519-24. doi: 10.1016/j.nut.2012.08.013. Epub 2012 Dec 28.

PMID:
23274089
22.

A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C.

Stathopoulou MG, Bonnefond A, Ndiaye NC, Azimi-Nezhad M, El Shamieh S, Saleh A, Rancier M, Siest G, Lamont J, Fitzgerald P, Visvikis-Siest S.

J Lipid Res. 2013 Feb;54(2):535-41. doi: 10.1194/jlr.P030551. Epub 2012 Dec 2. Erratum in: J Lipid Res. 2013 Mar;54(3):869.

23.

The theory of reference values: an unfinished symphony.

Siest G, Henny J, Gräsbeck R, Wilding P, Petitclerc C, Queraltó JM, Hyltoft Petersen P.

Clin Chem Lab Med. 2013 Jan;51(1):47-64. doi: 10.1515/cclm-2012-0682. Review.

PMID:
23183761
24.

Maintain the goals of Drug Metabolism and Drug Interactions.

Siest G.

Drug Metabol Drug Interact. 2012;27(4):183-4. doi: 10.1515/dmdi-2012-0037. No abstract available.

PMID:
23183743
25.

Clinical Chemistry and Laboratory Medicine: progress and new challenges for our 50-year-old journal.

Lippi G, Gillery P, Kazmierczak S, Lackner KJ, Melichar B, Siest G, Whitfield JB, Jahnke H, Plebani M.

Clin Chem Lab Med. 2013 Jan;51(1):5-7. doi: 10.1515/cclm-2012-0449. No abstract available.

PMID:
23093279
26.

Alcohol Consumption, Beverage Preference, and Diet in Middle-Aged Men from the STANISLAS Study.

Herbeth B, Samara A, Stathopoulou M, Siest G, Visvikis-Siest S.

J Nutr Metab. 2012;2012:987243. doi: 10.1155/2012/987243. Epub 2012 Sep 29.

27.

Clinical interest of point-of-care pharmacogenomic testing: clopidogrel behind warfarin.

Shahabi P, Siest G, Visvikis-Siest S.

Pharmacogenomics. 2012 Aug;13(11):1215-8. doi: 10.2217/pgs.12.85. No abstract available.

PMID:
22920390
28.

Drug metabolism and drug interactions and the European Society of Pharmacogenomics and Theranostics.

Siest G.

Drug Metabol Drug Interact. 2012;27(2):61. doi: 10.1515/dmdi-2012-0009. No abstract available.

PMID:
22706229
29.

Clinical necessity of partitioning of human plasma haptoglobin reference intervals by recently-discovered rs2000999.

Shahabi P, Siest G, Herbeth B, Ndiaye NC, Visvikis-Siest S.

Clin Chim Acta. 2012 Oct 9;413(19-20):1618-24. doi: 10.1016/j.cca.2012.04.033. Epub 2012 May 3.

PMID:
22579477
30.

A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levels.

Froguel P, Ndiaye NC, Bonnefond A, Bouatia-Naji N, Dechaume A, Siest G, Herbeth B, Falchi M, Bottolo L, Guéant-Rodriguez RM, Lecoeur C, Langlois MR, Labrune Y, Ruokonen A, El Shamieh S, Stathopoulou MG, Morandi A, Maffeis C, Meyre D, Delanghe JR, Jacobson P, Sjöström L, Carlsson LM, Walley A, Elliott P, Jarvelin MR, Dedoussis GV, Visvikis-Siest S.

PLoS One. 2012;7(3):e32327. doi: 10.1371/journal.pone.0032327. Epub 2012 Mar 5.

31.

High prevalence of metabolic syndrome in Iran in comparison with France: what are the components that explain this?

Azimi-Nezhad M, Herbeth B, Siest G, Dadé S, Ndiaye NC, Esmaily H, Hosseini SJ, Ghayour-Mobarhan M, Visvikis-Siest S.

Metab Syndr Relat Disord. 2012 Jun;10(3):181-8. doi: 10.1089/met.2011.0097. Epub 2012 Jan 27.

PMID:
22283632
32.

Identification of cis- and trans-acting genetic variants explaining up to half the variation in circulating vascular endothelial growth factor levels.

Debette S, Visvikis-Siest S, Chen MH, Ndiaye NC, Song C, Destefano A, Safa R, Azimi Nezhad M, Sawyer D, Marteau JB, Xanthakis V, Siest G, Sullivan L, Pfister M, Smith H, Choi SH, Lamont J, Lind L, Yang Q, Fitzgerald P, Ingelsson E, Vasan RS, Seshadri S.

Circ Res. 2011 Aug 19;109(5):554-63. doi: 10.1161/CIRCRESAHA.111.243790. Epub 2011 Jul 14.

33.

Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.

Albertini L, Siest G, Jeannesson E, Visvikis-Siest S.

Pharmacogenomics. 2011 May;12(5):681-91. doi: 10.2217/pgs.10.178. Review.

PMID:
21619430
34.

Pharmacogenomics and personalized medicine in clinical practice.

Manolopoulos VG, Dechairo B, Huriez A, Kühn A, Llerena A, van Schaik RH, Yeo KT, Ragia G, Siest G.

Pharmacogenomics. 2011 May;12(5):597-610. doi: 10.2217/pgs.11.14.

PMID:
21619425
35.

Functional genomics towards personalized healthcare and systems medicine.

Siest G, Nezhad MA, Bagrel D, El Shamieh S, Lambert D, Ndiaye NC, Shahabi P, Visvikis-Siest S.

Per Med. 2011 May;8(3):227-242. doi: 10.2217/pme.10.89.

36.

Biological and genetic factors associated with ABCB1 and pregnane-X-receptor expressions in peripheral blood mononuclear cells in the STANISLAS cohort.

Jeannesson E, Siest G, Herbeth B, Albertini L, Shahabi P, Pfister M, Visvikis-Siest S.

Drug Metabol Drug Interact. 2011;26(1):27-32. doi: 10.1515/DMDI.2011.102. Epub 2011 Mar 27.

PMID:
21438836
37.

Expression of inflammatory molecules and associations with BMI in children.

Dedoussis GV, Kapiri A, Samara A, Dimitriadis D, Lambert D, Pfister M, Siest G, Visvikis-Siest S.

Eur J Clin Invest. 2010 May;40(5):388-92. doi: 10.1111/j.1365-2362.2010.02277.x. Epub 2010 Mar 25.

PMID:
20345379
38.

Metabolic syndrome-related composite factors over 5 years in the STANISLAS family study: genetic heritability and common environmental influences.

Herbeth B, Samara A, Ndiaye C, Marteau JB, Berrahmoune H, Siest G, Visvikis-Siest S.

Clin Chim Acta. 2010 Jun 3;411(11-12):833-9. doi: 10.1016/j.cca.2010.02.070. Epub 2010 Feb 25.

PMID:
20219453
39.

Increasing laboratory medicine activities in China: research and publications.

Siest G.

Clin Chem Lab Med. 2009;47(10):1209. doi: 10.1515/CCLM.2009.293. No abstract available.

PMID:
19803810
40.

Adipokine expression in adipose tissue and in peripheral blood mononuclear cells in children Correlation with BMI and fatty acid content.

Dedoussis GV, Kapiri A, Kalogeropoulos N, Samara A, Dimitriadis D, Lambert D, Pfister M, Siest G, Visvikis-Siest S.

Clin Chim Acta. 2009 Dec;410(1-2):85-9. doi: 10.1016/j.cca.2009.09.028. Epub 2009 Sep 30.

PMID:
19800327
41.

Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases.

Zaiou M, Benachour H, Marteau JB, Visvikis-Siest S, Siest G.

Curr Pharm Des. 2009;15(27):3193-206. Review.

PMID:
19754391
42.

Human formyl peptide receptor 1 (FPR1) c.32C>T SNP is associated with decreased soluble E-selectin levels.

Benachour H, Zaiou M, Herbeth B, Lambert D, Lamont JV, Pfister M, Siest G, Tiret L, Blankenberg S, Fitzgerald PS, Visvikis-Siest S.

Pharmacogenomics. 2009 Jun;10(6):951-9. doi: 10.2217/pgs.09.29.

PMID:
19530962
43.

Personalized therapy and pharmacogenomics: future perspective.

Siest G, Marteau JB, Visvikis-Siest S.

Pharmacogenomics. 2009 Jun;10(6):927-30. doi: 10.2217/pgs.09.45. No abstract available.

44.

Drug metabolizing enzymes and transporters mRNA in peripheral blood mononuclear cells of healthy subjects: biological variations and importance of pre-analytical steps.

Siest G, Jeannesson E, Marteau JB, Samara A, Pfister M, Visvikis-Siest S.

Curr Drug Metab. 2009 May;10(4):410-9. Review.

PMID:
19519347
45.

Visfatin: the link between inflammation and childhood obesity.

Dedoussis GV, Kapiri A, Samara A, Dimitriadis D, Lambert D, Pfister M, Siest G, Visvikis-Siest S.

Diabetes Care. 2009 Jun;32(6):e71. doi: 10.2337/dc08-2304. No abstract available.

PMID:
19460907
46.

Sex-dependent associations of leptin with metabolic syndrome-related variables: the Stanislas study.

Samara A, Herbeth B, Aubert R, Berrahmoune H, Fumeron F, Siest G, Visvikis-Siest S.

Obesity (Silver Spring). 2010 Jan;18(1):196-201. doi: 10.1038/oby.2009.156. Epub 2009 May 14.

47.

Systems biology and personalized prevention.

Siest G.

Per Med. 2009 May;6(3):265-268. doi: 10.2217/pme.09.2. No abstract available.

48.

Parental precocious influences on offspring cardiovascular risk markers: an exploratory study in the STANISLAS Cohort.

Ndiaye NC, Albuisson É, Colombet I, Chatellier G, Marteau JB, Dadé S, Siest G, Visvikis-Siest S.

Per Med. 2009 May;6(3):343-352. doi: 10.2217/pme.09.11.

PMID:
29783507
49.

Association of human cathelicidin (hCAP-18/LL-37) gene expression with cardiovascular disease risk factors.

Benachour H, Zaiou M, Samara A, Herbeth B, Pfister M, Lambert D, Siest G, Visvikis-Siest S.

Nutr Metab Cardiovasc Dis. 2009 Dec;19(10):720-8. doi: 10.1016/j.numecd.2009.01.001. Epub 2009 Apr 5.

PMID:
19346112
50.

Association of ABCB1 gene polymorphisms with plasma lipid and apolipoprotein concentrations in the STANISLAS cohort.

Jeannesson E, Siest G, Bastien B, Albertini L, Aslanidis C, Schmitz G, Visvikis-Siest S.

Clin Chim Acta. 2009 May;403(1-2):198-202. doi: 10.1016/j.cca.2009.02.019. Epub 2009 Mar 11.

PMID:
19285054

Supplemental Content

Support Center